The safety of using anti-VEGF: Is there strength in numbers? Curtis LH,Hammill BG,Schulman KA,Cousins SW (2010) Risks of mortality,myocardial infarction,bleeding, and stroke associated with therapies for age-related macular degeneration. Arch Ophthalmol 128(10):1273–1279 |